Skip to main content

Malignant Mesenchymal Tumors

  • Chapter
  • First Online:
Pulmonary Pathology

Part of the book series: Essentials of Diagnostic Pathology ((ESSENTPATH))

  • 1283 Accesses

Abstract

Mesenchymal tumors of the lung are rare. Malignant mesenchymal tumors are even rarer compared to their benign counterparts. Most often sarcomas seen in the lung are metastatic, although in very rare instances a leiomyosarcoma might also arise locally in the bronchus. Other sarcomas can be seen combined with carcinomas such as carcinosarcoma. There are a few exceptions, such as angiogenic tumors. These will be discussed here.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 229.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 299.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Further Reading

  • Kitaichi M, Nagai S, Nishimura K, Itoh H, Asamoto H, Izumi T, Dail DH. Pulmonary epithelioid haemangioendothelioma in 21 patients, including three with partial spontaneous regression. Eur Respir J. 1998;12:89–96.

    Article  CAS  Google Scholar 

  • Cheuk W, Wong KO, Wong CS, Dinkel JE, Ben-Dor D, Chan JK. Immunostaining for human herpesvirus 8 latent nuclear antigen-1 helps distinguish Kaposi sarcoma from its mimickers. Am J Clin Pathol. 2004;121:335–42.

    Article  Google Scholar 

  • Stacher E, Gruber-Mosenbacher U, Halbwedl I, Dei Tos AP, Cavazza A, Papotti M, Carvalho L, Huber M, Ermert L, Popper HH. The VEGF-system in primary pulmonary angiosarcomas and haemangioendotheliomas: new potential therapeutic targets? Lung Cancer. 2009;65:49–55.

    Article  Google Scholar 

  • Miettinen M, Wang ZF. Prox1 transcription factor as a marker for vascular tumors-evaluation of 314 vascular endothelial and 1086 nonvascular tumors. Am J Surg Pathol. 2012;36:351–9.

    Article  Google Scholar 

  • Lamar JM, Motilal Nehru V, Weinberg G. Epithelioid Hemangioendothelioma as a Model of YAP/TAZ-Driven Cancer: Insights from a Rare Fusion Sarcoma. Cancers (Basel). 2018;10.

    Google Scholar 

  • Miettinen M, Rikala MS, Rys J, Lasota J, Wang ZF. Vascular endothelial growth factor receptor 2 as a marker for malignant vascular tumors and mesothelioma: an immunohistochemical study of 262 vascular endothelial and 1640 nonvascular tumors. Am J Surg Pathol. 2012;36:629–39.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Popper, H., Murer, B. (2020). Malignant Mesenchymal Tumors. In: Pulmonary Pathology. Essentials of Diagnostic Pathology. Springer, Cham. https://doi.org/10.1007/978-3-030-22664-0_15

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-22664-0_15

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-22662-6

  • Online ISBN: 978-3-030-22664-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics